Loading clinical trials...
Loading clinical trials...
To evaluate the effect of CS reducer implantation in patients with HFPEF and CMD on myocardial ischemia, measured by stress myocardial perfusion using cardiovascular magnetic resonance (CMR)
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Mayo Clinic
NCT07083011 · Heart Failure With Preserved Ejection Fraction
NCT07037459 · Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, and more
NCT07057466 · Valvular Heart Disease Stenosis and Regurgitation (Diagnosis), Pulmonary Hypertension (Diagnosis), and more
NCT07219511 · Heart, Heart Failure With Preserved Ejection Fraction (HFPEF)
NCT07272902 · Atrial Fibrillation (AF), Heart Failure With Mildly Reduced Ejection Fraction, and more
Mayo Clinic
Rochester, Minnesota
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions